US derma group defends isotretinoin acne treatment
This article was originally published in Scrip
Executive Summary
The acne drug isotretinoin, which was first launched in 1982 and is no longer sold by the originator of the product but by many generics firms, has been under attack for many years because of reports of serious side-effects. But in an updated position statement, the American Academy of Dermatology has defended the continued availability of the drug.